Fighting cancer from within

Lung cancer is the leading cause of cancer-related deaths in Australia, taking the lives of an estimated 8,900 people last year alone. 

CISL Team

SAiGENCI’s Tumour Inflammation and Immunotherapy team, Dr Ruby Dawson, Dr Mohamed Saad and Professor Brendan Jenkins (Program Lead).

Despite advances in treatment, the survival rate remains devastatingly low.  Too often, patients are faced with limited options as their cancer becomes resistant to therapy, or they experience some side effects.

Read more 

Tagged in SAiGENCI, cancer research, lung cancer, immunotherapy